Discussion This review systematically elucidates the pivotal role of ROS in regulating multiple PCD pathways and highlights the potential therapeutic value of targeting the ROSPCD network
BRASS, 2000 DUBELAAR et al, 1991
Semin Nephrol 28:477480 Summar M (2001) Current strategies for the management of neonatal urea cycle disorders
MATERIALS AND METHODS Materials Liraglutide was from Shoyaku (Fukuoka, Japan), U0126 and cerulein from Sigma-Aldrich (St Louis, MO, USA), Recombinant rat PDGF-BB from R&D Systems (Minneapolis, MN, USA) and rabbit anti-phosphorylated extracellular signal-regulated kinase (ERK) antibody, rabbit anti-phosphorylated JNK antibody, rabbit anti-phosphorylated p38 antibody, rabbit anti-phosphorylated Akt antibody, mouse anti-total I B antibody anti-rabbit IgG-HRP-conjugated antibody and anti-mouse IgG-HRP-conjugated antibody from Cell Signaling Technology (Beverly, MA, USA)
19 Ensures both physician and plan member signatures and dates are present and chronologically reasonable Require physician signature and physician signature date, and require plan member signature and date signed, since both attestations are necessary for consent and clinical authorization
